Difference between revisions of "Timeline of antibiotics"

From Timelines
Jump to: navigation, search
Line 10: Line 10:
 
| 19th century || Scientists begin to observe antibacterial chemicals in action.<ref name="THE HISTORY OF ANTIBIOTICS"/>
 
| 19th century || Scientists begin to observe antibacterial chemicals in action.<ref name="THE HISTORY OF ANTIBIOTICS"/>
 
|-
 
|-
−
| 20th century || {{w|Macrolide}}s are first discovered in the 1950s. In the 1970s and 1980s synthetic versions of {{w|erythromycin}}, including {{w|clarithromycin}} and {{w|azithromycin}}, are developed.<ref name="Ten important moments in the history of antibiotic discovery"/>
+
| 20th century || {{w|Macrolide}}s are first discovered in the 1950s.<ref name="Ten important moments in the history of antibiotic discovery"/> The period between the 1950s and 1970s is considered the golden era of discovery of novel antibiotics classes, with no new classes discovered since then.<ref name="A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future"/> In the 1970s and 1980s synthetic versions of {{w|erythromycin}}, including {{w|clarithromycin}} and {{w|azithromycin}}, are developed.<ref name="Ten important moments in the history of antibiotic discovery"/>
 
|-
 
|-
 
|}
 
|}
Line 18: Line 18:
 
{| class="sortable wikitable"
 
{| class="sortable wikitable"
 
! Year !! Event type !! Details !! Geographical location
 
! Year !! Event type !! Details !! Geographical location
 +
|-
 +
| 350 CE–550 CE || || Traces of {{w|tetracycline}} are found in human skeletal remains from ancient Sudanese Nubia.<ref name="A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future">{{cite journal|last1=Aminov|first1=Rustam I.|title=A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future|doi=10.3389/fmicb.2010.00134|pmid=21687759|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109405/|pmc=3109405}}</ref>
 
|-
 
|-
 
| 1909 || || German physician {{w|Paul Ehrlich}} discovers that a chemical called {{w|arsphenamine}} is an effective treatment for {{w|syphilis}}.<ref name="THE HISTORY OF ANTIBIOTICS"/>
 
| 1909 || || German physician {{w|Paul Ehrlich}} discovers that a chemical called {{w|arsphenamine}} is an effective treatment for {{w|syphilis}}.<ref name="THE HISTORY OF ANTIBIOTICS"/>

Revision as of 11:33, 29 March 2018

This is a timeline of FIXME.

Big picture

Time period Development summary More details
<19th century although people did not know infections were caused by bacteria, antibiotics have been used for millennia to treat infections. Some of the earliest civilizations used various moulds and plant extracts to treat infections. The ancient Egyptians, for example, applied mouldy bread to infected wounds.[1]
19th century Scientists begin to observe antibacterial chemicals in action.[1]
20th century Macrolides are first discovered in the 1950s.[2] The period between the 1950s and 1970s is considered the golden era of discovery of novel antibiotics classes, with no new classes discovered since then.[3] In the 1970s and 1980s synthetic versions of erythromycin, including clarithromycin and azithromycin, are developed.[2]

Full timeline

Year Event type Details Geographical location
350 CE–550 CE Traces of tetracycline are found in human skeletal remains from ancient Sudanese Nubia.[3]
1909 German physician Paul Ehrlich discovers that a chemical called arsphenamine is an effective treatment for syphilis.[1]
1932 German pathologist Gerhard Domagk develops prontosil, the first sulphonamide microbial.[4][5][6] Germany
1942 Penicillin is introduced.[6]
1943 American biochemists Selman Waksman, Albert Schatz, and Elizabeth Bugie discover antibiotic Streptomycin, the first aminoglycoside. It is the first antibiotic effective against tuberculosis.[2][7][8][9][6] United States
1945 The cephalosporins are discovered from a fungus, Cephalosporium acremonium, in seawater samples near a sewage outfall in Sardinia.[6][10][11][12] Italy
1947 Chloramphenicol is isolated from the soil organism Streptomyces venezuelae. Merketed in 1949, its use would quickly become widespread due to its broad spectrum of antimicrobial activity.[13][14][15][16]
1947 American plant physiologist Benjamin Minge Duggar isolates chlortetracycline from a Missouri River mud sample. It is the first tetracycline introduced.[17][18][19][20] United States
1949 Jewish-American biochemist Selman Waksman and Hubert A. Lechevalier first isolate neomycin, as aminoglycoside antibiotic found in many topical medications such as creams, ointments, and eyedrops.[21][22][23] United States
1952 Eli Lilly and Company introduces erythromycin, an antibiotic useful for the treatment of a number of bacterial infections, including respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis.[24][25][26] United States
1953 Oxford University scientists discover antibiotic cephalosporin C.[2] United Kingdom
1956 Research team at the Lilly Biological Laboratories in Indiana first isolates vancomycin from bacterium streplomyces orienlalis. Vancomycin is used as a treatment for complicated skin infections, bloodstream infections, endocarditis, bone and joint infections, and meningitis caused by methicillin-resistant staphylococcus aureus.[6][27][28][29] United States
1961 Antibiotic ampicillin is introduced. Within a short time it would become the drug of choice for treatment of Hemophilus influenzae meningitis.[30][31][32][6]
1961 Resistance Methicillin-resistant staphylococcus aureus is first reported in the United Kingdom, just a year after the antibiotic methicillin was introduced in the country.[2]
1962 Quinolones are discovered accidentally, as a byproduct of some research on the antimalarial drug chloroquine.[2]
1963 Weinstein and his colleagues from the Schering Corporation describe the first isolation of the gentamicin complex.[6][33][34][35] United States
1965 Dicloxacillin is synthesized by Bayer.[36][37][38]
1966 Antibiotic doxycycline is introduced.[39][40][41][6]
1968 Antibiotic rifampicin is introduced for clinical use.[42][43][44] Italy
1970 Non-toxic semi-synthetic acid-resistant isoxazolyl penicillin flucloxacillin is introduced into clinical practice.[38][45]
1972 Antibiotic minocycline is discovered.[39][40][41]
1974 Antibiotic trimethoprim/sulfamethoxazole is commercially released.[46][6]
1976 Antibiotic amikacin is introduced.[6]
1984 Antibiotic ampicillin/clavulanate is introduced.[6]
1985 Researchers at Eli Lilly and Company discover antibiotic daptomycin.[47][48][49] United States
1987 Antibiotic imipenem/cilastin is introduced.[6]
1987 Antibiotic ciprofloxacin is introduced.[6]
1993 Antibiotics azithromycin and clarithromycin are introduced.[6]
1999 Antibiotic quinupristin/dalfopristin is introduced.[6]
2000 Antibiotic linezolid is introduced.[6]
2001 Antibiotic telithromycin is introduced in the European Union.[50][51][52]
2003 Antibiotic daptomycin is introduced.[6]
2005 Antibiotic tigecycline is introduced for the treatment of skin and skin structure infections and intraabdominal infections.[53][54][55]

Meta information on the timeline

How the timeline was built

The initial version of the timeline was written by FIXME.

Funding information for this timeline is available.

Feedback and comments

Feedback for the timeline can be provided at the following places:

  • FIXME

What the timeline is still missing

[1], [2], [3], [4], [5], [6] [7], [8]

Timeline update strategy

See also

External links

References

  1. ↑ 1.0 1.1 1.2 "THE HISTORY OF ANTIBIOTICS". microbiologysociety.org. Retrieved 29 March 2018. 
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 "Ten important moments in the history of antibiotic discovery". correctiv.org. Retrieved 29 March 2018. 
  3. ↑ 3.0 3.1 Aminov, Rustam I. "A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future". PMC 3109405Freely accessible. PMID 21687759. doi:10.3389/fmicb.2010.00134. 
  4. ↑ Ravina, Enrique. The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. 
  5. ↑ Savona-Ventura, Charles. Contemporary Medicine in Malta [1798-1979]. 
  6. ↑ 6.00 6.01 6.02 6.03 6.04 6.05 6.06 6.07 6.08 6.09 6.10 6.11 6.12 6.13 6.14 6.15 6.16 Torok, Estee; Moran, Ed; Cooke, Fiona. Oxford Handbook of Infectious Diseases and Microbiology. 
  7. ↑ Lorian, Victor. Antibiotics in Laboratory Medicine. 
  8. ↑ Morabia, Alfredo. Enigmas of Health and Disease: How Epidemiology Helps Unravel Scientific Mysteries. 
  9. ↑ Cumo, Christopher Martin. The Ongoing Columbian Exchange: Stories of Biological and Economic Transfer in World History: Stories of Biological and Economic Transfer in World History. 
  10. ↑ Stephanie Watts; Faingold, Carl; Dunaway, George; Crespo, Lynn. Brody's Human Pharmacology - E-Book. 
  11. ↑ Riviere, Jim E.; Papich, Mark G. Veterinary Pharmacology and Therapeutics. 
  12. ↑ Bennett, Peter N.; Brown, Morris J. Clinical Pharmacology E-Book: With STUDENTCONSULT Access. 
  13. ↑ Kacew, Sam. Drug Toxicity and Metabolism in Pediatrics. 
  14. ↑ Riviere, Jim E.; Papich, Mark G. Veterinary Pharmacology and Therapeutics. 
  15. ↑ Shapiro, Stuart. Regulation of Secondary Metabolism in Actinomycetes. 
  16. ↑ Aschenbrenner, Diane S.; Venable, Samantha J. Drug Therapy in Nursing. 
  17. ↑ Dougherty, Thomas J.; Pucci, Michael J. Antibiotic Discovery and Development. 
  18. ↑ Kokate, Chandrakant; Jalalpure, SS; Pramod, H.J. Textbook of Pharmaceutical Biotechnology - E-Book. 
  19. ↑ Advances in Pharmacology and Chemotherapy. 
  20. ↑ McKenna, John. Natural Alternatives to Antibiotics – Revised and Updated: How to treat infections without antibiotics. 
  21. ↑ Schindel, Leo. Unexpected Reactions to Modern Therapeutics: Antibiotics. 
  22. ↑ Grayson, M Lindsay; Crowe, Suzanne M; McCarthy, James S; Mills, John; Mouton, Johan W; Norrby, S Ragnar; Paterson, David L; Pfaller, Michael A. Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. 
  23. ↑ Advances in Carbohydrate Chemistry, Volume 18. 
  24. ↑ Rubin, Bruce K.; Tamaoki, Jun. Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. 
  25. ↑ Piscitelli, Stephen C.; Rodvold, Keith A.; Pai, Manjunath P. Drug Interactions in Infectious Diseases. 
  26. ↑ Nightingale; Mur. Antimicrobial Pharmacodynamics in Theory and Clinical Practice, Second Edition. 
  27. ↑ Staphylococci in Human Disease (Kent B. Crossley, Kimberly K. Jefferson, Gordon L. Archer, Vance G. Fowler ed.). 
  28. ↑ Antibiotics Annual. 
  29. ↑ Hejzlar, Miroslav. Advances in Antimicrobial and Antineoplastic Chemotherapy: Progress in Research and Clinical Application: pt. 1-2. Antimicrobial chemotherapy. 
  30. ↑ Atta-ur-Rahman. Studies in Natural Products Chemistry, Volume 56. 
  31. ↑ Thompson, R.A.; Green, John R. Infectious Diseases of the Central Nervous System. 
  32. ↑ Fifty Years of Antimicrobials: Past Perspectives and Future Trends. Society for General Microbiology. Symposium. 
  33. ↑ Advances in Applied Microbiology, Volume 18. 
  34. ↑ Eardley, Ian; Whelan, Peter; Kirby, Roger; Schaeffer, Anthony. Drug Treatment in Urology. 
  35. ↑ Antimicrobials: Synthetic and Natural Compounds (Dharumadurai Dhanasekaran, Nooruddin Thajuddin, A. Panneerselvam ed.). 
  36. ↑ McGuire, John L. Pharmaceuticals, 4 Volume Set. 
  37. ↑ Kuemmerle, Helmut Paul. Clinical Chemotherapy: Antimicrobial Chemotherapy. 
  38. ↑ 38.0 38.1 Harper, N. J.; Simmonds, Alma B. Advances in Drug Research, Volume 7. 
  39. ↑ 39.0 39.1 Yaffe, Sumner J.; Aranda, Jacob V. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. 
  40. ↑ 40.0 40.1 Denyer, Stephen P.; Hodges, Norman A.; Gorman, Sean P.; Gilmore, Brendan F. Hugo and Russell's Pharmaceutical Microbiology. 
  41. ↑ 41.0 41.1 Dirnagl, Ulrich; Elger, Bernd. Neuroinflammation in Stroke. 
  42. ↑ Rahman, Atta -ur-; Choudhary, M. Iqbal. Frontiers in Anti-Infective Drug Discovery, Volume 6. 
  43. ↑ Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set (y M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson ed.). 
  44. ↑ Mann, R.D. Modern Drug use: An Enquiry on Historical Principles. 
  45. ↑ Neonatal Formulary. BMJ Books, 2000. 
  46. ↑ "Pharmaceutical Marketing in India". books.google.com.ar. Retrieved 28 March 2018. 
  47. ↑ Current Medical Research and Opinion, Volume 22, Issues 9-12. Clayton-Wray Publications Limited, 2006. 
  48. ↑ Rybak, M. J. "The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram‐positive bacteria". 
  49. ↑ Beiras-Fernandez, Andres; Ferdinand Vogt, Ferdinand Vogt; Sodian, Ralf; Weis, Florian. "Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens". PMC 3108743Freely accessible. PMID 21694898. doi:10.2147/IDR.S6961. 
  50. ↑ Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set (M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson ed.). 
  51. ↑ Alex, Alexander; Harris, C. John; Smith, Dennis A. Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward. 
  52. ↑ Hugo and Russell's Pharmaceutical Microbiology (Stephen P. Denyer, Norman A. Hodges, Sean P. Gorman, Brendan F. Gilmore ed.). 
  53. ↑ Low-dose antibiotics: current status and outlook for the future (Robert Paul Hunter, Carlos F Amábile-Cuevas, Jun Lin, Joshua D Nosanchuk, Rustam Aminov ed.). 
  54. ↑ Vincent, Jean-Louis; Abraham, Edward; Kochanek, Patrick; Moore, Frederick A.; Fink, Mitchell P. Textbook of Critical Care E-Book. 
  55. ↑ Trauma: Critical Care (William C. Wilson, Christopher M. Grande, David B. Hoyt ed.). 
Retrieved from "http://timelines.issarice.com/index.php?title=Timeline_of_antibiotics&oldid=21256"